Lopinavir
| CAS No. | 192725-17-0 |
|---|---|
| MDL No. | MFCD22373646 |
| MF | C37H48N4O5 |
| MW | 628.80 |
| InChI Key | KJHKTHWMRKYKJE-SUGCFTRWSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Lopinavir is a dicarboxylic acid diamide with an amphetamine structure substituted on nitrogen by a (2,6-dimethylphenoxy)acetyl group and on the alpha-carbon to nitrogen by a (1S,3S)-1-hydroxy-3-{[(2S)-3-methyl-2-(2-oxotetrahydropyrimidin-1-yl)butanoyl]amino}-4-phenylbutyl group. It is an antiretroviral protease inhibitor used in HIV treatment as a fixed-dose combination with ritonavir. It functions as an antiviral drug, HIV protease inhibitor, and anticoronaviral agent. It belongs to the class of amphetamines and dicarboxylic acid diamides.
| CAS No. | 192725-17-0 |
|---|---|
| Product Name | Lopinavir |
Associated Conditions
Kaposi's sarcoma·COVID-19·hepatitis C virus infection·anal neoplasm·Insulin resistance·
* The information provided here is compiled from public sources and is for reference only.